Prevail Therapeutics, Inc. announced the appointment of Brett Kaplan, M.D., to Chief Financial Officer. In addition, Emily Minkow was promoted to Chief Business Officer from her former role as Executive Vice President of Business Development and Strategy. Dr. Kaplan joins Ms. Minkow and Prevail's existing executive team: Franz Hefti, Ph.D., Chief Development Officer; Jeffrey Sevigny, M.D., Chief Medical Officer and Founder and CEO Asa Abeliovich, M.D., Ph.D. Prior to Prevail, Dr. Kaplan was a Managing Director at Evercore, where he spent eight years concentrating on biopharma M&A and equity financings.

Prior to Prevail, Ms. Minkow held positions of increasing responsibility at Celgene Corporation for seven years, most recently as Executive Director of Business Development.